TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2.
Liu YX, Wan S, Yang XQ, Wang Y, Gan WJ, Ye WL, He XS, Chen JJ, Yang Y, Yang XM, et al. Cell Chem Biol. 2023 Jul 20; 30(7):709-725.e6. Epub 2023 Jun 23.